A
$ Value
$0
Shares
1,080
Price
$0
Filed
Jul 1
Insider
Name
Samuels Theodore R. II
Title
—
CIK
0001688276
Roles
Director
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
59,477
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. | Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
Filing Info
Samuels Theodore R. II's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | IRM | A | $36K |
| 2026-04-06 | IRM | A | $10K |
| 2026-03-31 | CNC | A | $0 |
| 2026-03-31 | BMY | A | $51K |
| 2026-02-01 | BMY | A | $220K |
| 2026-01-06 | IRM | A | $36K |
| 2026-01-06 | IRM | A | $9K |
| 2025-12-31 | BMY | A | $0 |
| 2025-12-31 | CNC | A | $0 |
| 2025-10-03 | IRM | A | $8K |
Other Insiders at BMY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| YALE PHYLLIS R | — | — | 2026-03-31 |
| Arduini Peter J | — | — | 2026-03-31 |
| Rice Derica W | — | — | 2026-03-31 |
| Price Paula A | — | — | 2026-02-01 |
| McMullen Michael R. | — | — | 2026-03-31 |
|
Elkins David V
EVP, Chief Financial Officer
|
— | $1.9M | 2026-04-01 |
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
|
— | — | 2026-03-10 |
| Haller Julia A | — | — | 2026-02-01 |
| Samuels Theodore R. II | — | — | 2026-03-31 |
| Vousden Karen H | — | — | 2026-02-01 |
|
Hickey Benjamin
President, RayzeBio Org.
|
— | — | 2026-03-10 |
|
Plenge Robert M
EVP, Chief Research Officer
|
— | — | 2026-03-10 |
| Hidalgo Medina Manuel | — | — | 2026-02-01 |
|
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
|
— | — | 2026-03-10 |
|
Shanahan Karin
EVP, Chief Supply Chain & Ops
|
— | — | 2026-04-01 |
| Bhatt Deepak | — | — | 2026-02-01 |
|
Lenkowsky Adam
EVP, Chief Commercial Officer
|
— | — | 2026-03-10 |
|
Gallman Cari
EVP, General Counsel
|
— | — | 2026-03-10 |
|
Poole Ahn Amanda
EVP, Chief People Officer
|
— | — | 2026-03-10 |
|
Hoch Lynelle
President, Cell Therapy Org.
|
— | — | 2026-03-10 |
|
Holzer Phil M
SVP and Controller
|
— | — | 2026-03-10 |
|
Short Bartie Wendy
EVP, Corporate Affairs
|
— | — | 2026-03-10 |
|
Shibutani Hiroshi Chris
EVP, Chief Strategy Officer
|
— | — | 2026-03-10 |
|
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
|
— | — | 2026-03-10 |